These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 33976642

  • 1. Adjuvant Treatment of the Salivary Duct Carcinoma with Her2 Overexpression.
    Berendika J, Jungić S, Tubić B, Malčić Kecman G, Rakita I, Gojković Z, Vještica M, Nikić G, Babić B.
    Case Rep Oncol; 2021; 14(1):610-615. PubMed ID: 33976642
    [Abstract] [Full Text] [Related]

  • 2. Clinicopathological features and treatment outcomes of the rare, salivary duct carcinoma of parotid gland.
    Al-Qahtani KH, Tunio MA, Bayoumi Y, Gurusamy VM, Bahamdain FA, Fatani H.
    J Otolaryngol Head Neck Surg; 2016 May 16; 45(1):32. PubMed ID: 27184361
    [Abstract] [Full Text] [Related]

  • 3. Salivary duct carcinoma of the parotid gland: A case report and review of the literature.
    Xie S, Yang H, Bredell M, Shen S, Yang H, Jin L, Zhang S.
    Oncol Lett; 2015 Jan 16; 9(1):371-374. PubMed ID: 25435994
    [Abstract] [Full Text] [Related]

  • 4. Second-Line Treatment of HER2-Positive Salivary Gland Tumor: Ado-Trastuzumab Emtansine (T-DM1) after Progression on Trastuzumab.
    Corrêa TS, Matos GDR, Segura M, Dos Anjos CH.
    Case Rep Oncol; 2018 Jan 16; 11(2):252-257. PubMed ID: 29867432
    [Abstract] [Full Text] [Related]

  • 5. Salivary Duct Carcinoma: Case Reports and Brief Review of the Literature.
    Kantamani D, Bandaru SS, Miatech JL, Stagg MP.
    Case Rep Oncol Med; 2021 Jan 16; 2021():2672772. PubMed ID: 34671494
    [Abstract] [Full Text] [Related]

  • 6. Salivary duct carcinoma of the parotid gland.
    Mlika M, Kourda N, Zidi Y, Aloui R, Zneidi N, Rammeh S, Zermani R, Jilani SB.
    J Oral Maxillofac Pathol; 2012 Jan 16; 16(1):134-6. PubMed ID: 22434951
    [Abstract] [Full Text] [Related]

  • 7. Parotid salivary duct carcinoma: a single institution's 20-year experience.
    Stodulski D, Mikaszewski B, Majewska H, Kuczkowski J.
    Eur Arch Otorhinolaryngol; 2019 Jul 16; 276(7):2031-2038. PubMed ID: 31062093
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Combination Chemohormonal Therapy in Metastatic Salivary Duct Carcinoma.
    Jeong ISD, Moyers J, Thung I, Thinn MM.
    Am J Case Rep; 2020 Jun 30; 21():e925181. PubMed ID: 32601266
    [Abstract] [Full Text] [Related]

  • 11. Bone marrow metastases in salivary duct carcinoma of the parotid gland.
    Asarkar A, Takalkar A, Dhawan M, Nathan CAO.
    BMJ Case Rep; 2018 Dec 03; 11(1):. PubMed ID: 30567167
    [Abstract] [Full Text] [Related]

  • 12. Successful multimodal treatment of intraoral salivary duct carcinoma in a patient with multiple lymph node metastases: a case report.
    Imaue S, Tomihara K, Hamashima T, Tomizawa G, Nomura K, Sasahara M, Noguchi M.
    World J Surg Oncol; 2017 Jan 10; 15(1):18. PubMed ID: 28073374
    [Abstract] [Full Text] [Related]

  • 13. HER2/neu negative salivary duct carcinoma of parotid: A case with forty months recurrence free follow up.
    Gokavarapu S, Fonseca D, Puthamakula S, Reddy BP, Reddy BS, Murthy S.
    Int J Surg Case Rep; 2015 Jan 10; 8C():22-4. PubMed ID: 25603487
    [Abstract] [Full Text] [Related]

  • 14. Salivary duct carcinoma: a clinical and histologic review with implications for trastuzumab therapy.
    Nabili V, Tan JW, Bhuta S, Sercarz JA, Head CS.
    Head Neck; 2007 Oct 10; 29(10):907-12. PubMed ID: 17563907
    [Abstract] [Full Text] [Related]

  • 15. Metastatic Salivary Duct Carcinoma with ERBB2 Amplification and Sequential Response to Ado-Trastuzumab Emtansine and Neratinib: A Case Report.
    Asper N, Roth KS, Hany TF, Salzberg SP, Tinguely M, Kadvany Y, Trojan A.
    Case Rep Oncol; 2023 Oct 10; 16(1):1500-1507. PubMed ID: 38033416
    [Abstract] [Full Text] [Related]

  • 16. Invasive micropapillary salivary duct carcinoma mixed with mucin-rich salivary duct carcinoma in minor salivary gland: a rare case report.
    Tomihara K, Miwa S, Takazakura T, Kamisaki Y, Noguchi M.
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2016 Jun 10; 121(6):e162-7. PubMed ID: 26725719
    [Abstract] [Full Text] [Related]

  • 17. Salivary duct carcinoma--a highly aggressive salivary gland tumor with HER-2/neu oncoprotein overexpression.
    Skálová A, Stárek, Kucerová V, Szépe P, Plank L.
    Pathol Res Pract; 2001 Jun 10; 197(9):621-6. PubMed ID: 11569926
    [Abstract] [Full Text] [Related]

  • 18. Low grade salivary duct carcinoma. A distinctive variant with a low grade histology and a predominant intraductal growth pattern.
    Delgado R, Klimstra D, Albores-Saavedra J.
    Cancer; 1996 Sep 01; 78(5):958-67. PubMed ID: 8780532
    [Abstract] [Full Text] [Related]

  • 19. Comprehensive diagnosis and treatment of ductal carcinoma of the submandibular gland: case report and literature review.
    Liu F, Fan L, Lu L, Guo H, Nan J, Han F.
    Int J Clin Exp Pathol; 2023 Sep 01; 16(3):67-75. PubMed ID: 37033394
    [Abstract] [Full Text] [Related]

  • 20. Salivary duct carcinoma in the mandible: a case report.
    Kikuchi Y, Hirota M, Iwai T, Aoki S, Chikumaru H, Kawabe R, Matsui Y.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Mar 01; 103(3):e41-6. PubMed ID: 17321438
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.